BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $781,966 | -27.8% | 41,906 | -16.9% | 0.02% | -36.0% |
| Q4 2022 | $1,083,666 | -51.9% | 50,450 | -53.2% | 0.02% | -51.9% |
| Q1 2022 | $2,252,000 | +977.5% | 107,700 | +1398.7% | 0.05% | +642.9% |
| Q2 2021 | $209,000 | -88.0% | 7,186 | -78.1% | 0.01% | -94.1% |
| Q2 2020 | $1,742,000 | -8.5% | 32,865 | -61.4% | 0.12% | -24.7% |
| Q1 2020 | $1,903,000 | +395.6% | 85,154 | +224.3% | 0.16% | +378.8% |
| Q4 2019 | $384,000 | – | 26,255 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |